EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $20,000 | -98.6% | 1,165 | -98.1% | 0.00% | -98.9% |
| Q2 2015 | $1,440,000 | -82.4% | 60,000 | -86.1% | 0.09% | -87.3% |
| Q4 2014 | $8,164,000 | +6.1% | 432,619 | +52.4% | 0.68% | -17.1% |
| Q3 2014 | $7,696,000 | +480.4% | 283,890 | +566.4% | 0.83% | +535.4% |
| Q2 2014 | $1,326,000 | +10.7% | 42,602 | -19.0% | 0.13% | +3.2% |
| Q1 2014 | $1,198,000 | +136.8% | 52,602 | +192.2% | 0.13% | +147.1% |
| Q2 2013 | $506,000 | – | 18,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |